Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Molecular Cancer Research : MCR|May 22, 2019
Identification of TP53RK-Binding Protein (TPRKB) Dependency in TP53-Deficient CancersMoloy T Goswami, Kelly R VanDenBerg, Sumin Han, et al.
Molecular Cancer Research : MCR|January 22, 2016
BET Bromodomain Inhibitors Enhance Efficacy and Disrupt Resistance to AR Antagonists in the Treatment of Prostate CancerIrfan A Asangani, Kari Wilder-Romans, Vijaya L Dommeti, et al.
Cancer Research|June 15, 2018
EWS/ETS-Driven Ewing Sarcoma Requires BET Bromodomain ProteinsParadesi Naidu Gollavilli, Aishwarya Pawar, Kari Wilder-Romans, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2016
Maternal Embryonic Leucine Zipper Kinase (MELK) as a Novel Mediator and Biomarker of Radioresistance in Human Breast CancerCorey Speers, Shuang G Zhao, Vishal Kothari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 29, 2019
Functional and Mechanistic Interrogation of BET Bromodomain Degraders for the Treatment of Metastatic Castration-resistant Prostate CancerSteven Kregel, Rohit Malik, Irfan A Asangani, et al.
International Journal of Radiation Oncology, Biology, Physics|May 21, 2020
A Signature That May Be Predictive of Early Versus Late Recurrence After Radiation Treatment for Breast Cancer That May Inform the Biology of Early, Aggressive RecurrencesCorey Speers, S Laura Chang, Andrea Pesch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 24, 2020
Short-term CDK4/6 Inhibition Radiosensitizes Estrogen Receptor-Positive Breast CancersAndrea M Pesch, Nicole H Hirsh, Benjamin C Chandler, et al.
Molecular Cancer Therapeutics|August 16, 2019
PARP1 Inhibition Radiosensitizes Models of Inflammatory Breast Cancer to Ionizing RadiationAnna R Michmerhuizen, Andrea M Pesch, Leah Moubadder, et al.
Cancer Research|December 8, 2016
Glioblastoma Therapy Can Be Augmented by Targeting IDH1-Mediated NADPH BiosynthesisDaniel R Wahl, Joseph Dresser, Kari Wilder-Romans, et al.
Cancer Research Communications|November 16, 2022
Bcl-xL inhibition radiosensitizes PIK3CA/PTEN wild-type triple negative breast cancers with low Mcl-1 expressionAndrea M Pesch, Benjamin C Chandler, Anna R Michmerhuizen, et al.
Pageof 5